Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cancer Radiother ; 21(6-7): 584-596, 2017 Oct.
Artículo en Francés | MEDLINE | ID: mdl-28886981

RESUMEN

Radiation-induced lung disease (RILD) is common after radiation therapy and represents cornerstone toxicities after treatment of thoracic malignancies. From a review of literature, the objective of this article was to summarize clinical and non-clinical parameters associated with the risk of RILD in the settings of normo-fractionated radiotherapy and stereotactic body radiation therapy (SBRT). For the treatment of lung cancers with a normo-fractionated treatment, the mean lung dose (MLD) should be below 15-20Gy. For a thoracic SBRT, V20Gy<10% and MLD<6Gy are recommended. One should pay attention to central tumors and respect specific dose constraints to the bronchial tree. The recent technological improvements may represent an encouraging way to decrease lung toxicities. Finally, our team developed a calculator in order to predict the risk of radiation pneumonitis.


Asunto(s)
Fraccionamiento de la Dosis de Radiación , Enfermedades Pulmonares/etiología , Neoplasias Pulmonares/radioterapia , Pulmón/efectos de la radiación , Órganos en Riesgo/efectos de la radiación , Radiocirugia/métodos , Humanos , Neumonitis por Radiación/etiología , Neoplasias Torácicas/radioterapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...